CD8A and COVID-19: In turn, LaVergne et al. [37] have demonstrated that in the acute COVID-19 phase, CD8+ (CD8+ Ki67+) T cells were significantly higher in patients who developed persistent dyspnea, while CD4+ CD25+ T cells were increased in those who later developed persistent forgetfulness.